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In 2005, the International Association for the Study of Lung Cancer (IASLC) ended their publishing agreement with Elsevier, signed an agreement with Lippincott Williams & 
Wilkins (LWW), and the Journal of Thoracic Oncology was born. This December issue of 
the journal is the last to be published with LWW. Starting January 1, 2016, the new pub-
lisher of the journal will be Elsevier. Indeed, “the more things change, the more they stay 
the same.”
At this juncture, I would like to express the gratitude of the current Editorial Board to 
a number of individuals and entities who have contributed to the success of this journal over 
the past decade. First, the IASLC membership and Board of Directors have helped support 
and guide the journal over the years. Members are loyal and dedicated to the journal, and 
the IASLC executives and board members have always given their guidance and support. 
Second, I would like to thank our inaugural editor-in-chief Dr. James Jett and his editorial 
team for launching and growing the journal for the ﬁrst 7 years. Finally, our publisher LWW 
has been pivotal in the growth of the journal, which they leave with an excellent reputation 
and high visibility.
As we move into the second decade of the Journal of Thoracic Oncology, please mull 
over a few facts that attest to the dedication, vision, and hard work of all those acknowl-
edged here.
The ﬁrst impact factor in 2007 was 1.429, it is now 5.282. In 2005, 108 manuscripts 
were submitted to the journal, and in 2014, it was 1256. In 2005, it took an average of 30 
days from the receipt of an article to the ﬁrst decision being rendered. In 2014, it took 
12.3 days. In 2005, we received submissions from 17 countries, and in 2015, submissions 
have been received from at least 43 countries.
Indeed the journal has grown over the last 10 years and admirably serves the global 
oncology and research community. We thank all of our supporters and look forward to an 
even more dramatic growth over the next decade.
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